Hepatitis B Virus-associated Liver Failure in a Patient With B-cell Non-Hodgkin Lymphoma After Anti-cancer Therapy Including Ibrutinib

Clin Lymphoma Myeloma Leuk. 2020 Mar;20(3):e124-e127. doi: 10.1016/j.clml.2019.12.006. Epub 2019 Dec 24.

¹ Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX.
² Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
³ Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX.
⁴ Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
⁵ Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: [email protected].

No abstract available

Keywords: Hepatitis B virus; Hodgkin lymphoma; Ibrutinib; Liver failure; Reactivation.

Publication types